Livotuff Tablet MD Orange contains Levocetirizine 5 mg, a third-generation non-sedative antihistamine used primarily for the relief of allergy symptoms. Levocetirizine acts as a selective antagonist of peripheral H1 histamine receptors, effectively reducing the effects of histamine in allergic conditions. This medication is indicated for the treatment of allergic rhinitis, including seasonal and perennial types, as well as chronic idiopathic urticaria characterized by itching and hives. Livotuff Tablet MD Orange provides rapid symptomatic relief from sneezing, nasal congestion, runny nose, itchy and watery eyes, and skin rashes associated with allergic reactions. Due to its high selectivity and minimal penetration of the blood-brain barrier, it has a lower risk of sedation compared to first-generation antihistamines. The recommended dosage for adults and children over 12 years is one tablet once daily, preferably in the evening. Caution is advised in patients with renal impairment, and dose adjustment may be necessary. Livotuff Tablet MD Orange should be used under medical supervision, especially in pregnant or lactating women. Common adverse effects include headache, dry mouth, and fatigue, which are generally mild and transient. Avoid concurrent use with other CNS depressants unless directed by a healthcare professional.